Description
ML264 is a Krüppel-like factor 5 (KLF5) inhibitor with the potential to inhibits growth of colorectal cancer. It reduces EGR1 and KLF5 levels so that ML264 inhibits the MAPK pathway.
in a cell-based assay for proliferation of DLD-1 cells: IC50 = 29 nM, in